Canada markets closed

Immunome, Inc. (IMNM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
15.75+0.78 (+5.21%)
At close: 04:00PM EDT
15.75 0.00 (0.00%)
After hours: 07:28PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 944.11M
Enterprise Value 803.61M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)22.30
Price/Book (mrq)7.88
Enterprise Value/Revenue 57.33
Enterprise Value/EBITDA -28.70

Trading Information

Stock Price History

Beta (5Y Monthly) 1.66
52-Week Change 3159.90%
S&P500 52-Week Change 322.38%
52 Week High 330.96
52 Week Low 34.50
50-Day Moving Average 321.24
200-Day Moving Average 312.79

Share Statistics

Avg Vol (3 month) 3842.71k
Avg Vol (10 day) 31.05M
Shares Outstanding 559.94M
Implied Shares Outstanding 659.94M
Float 844.1M
% Held by Insiders 118.02%
% Held by Institutions 140.44%
Shares Short (Apr 15, 2024) 43.75M
Short Ratio (Apr 15, 2024) 46.26
Short % of Float (Apr 15, 2024) 46.64%
Short % of Shares Outstanding (Apr 15, 2024) 46.28%
Shares Short (prior month Mar 15, 2024) 43.01M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-362.02%

Management Effectiveness

Return on Assets (ttm)-20.81%
Return on Equity (ttm)-156.45%

Income Statement

Revenue (ttm)14.02M
Revenue Per Share (ttm)0.71
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -28.27M
Net Income Avi to Common (ttm)-106.81M
Diluted EPS (ttm)-5.38
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)142.15M
Total Cash Per Share (mrq)2.38
Total Debt (mrq)1.65M
Total Debt/Equity (mrq)1.38%
Current Ratio (mrq)6.63
Book Value Per Share (mrq)2.77

Cash Flow Statement

Operating Cash Flow (ttm)-7.57M
Levered Free Cash Flow (ttm)2.36M